Firm may have blood test to determine presence of Alzheimer's

03/15/2007 | Yahoo!

France's ExonHit Therapeutics says it has identified a set of genes that may allow it to analyze blood samples to determine if a patient has Alzheimer's disease. In one study involving a group of 85 people, the firm said, the process was able to identify 78% of the people with Alzheimer's and 82% of those without it.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC
Senior Counsel Commercial
RAI Services Company
Winston Salem, NC
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL